Imatinib (Gleevec®) as a paradigm of targeted cancer therapies

Research output: Contribution to journalArticle

5 Scopus citations
Original languageEnglish (US)
Pages (from-to)1-3
Number of pages3
JournalKeio Journal of Medicine
Volume59
Issue number1
DOIs
StatePublished - Mar 1 2010

Keywords

  • CML
  • Imanitib
  • Leukemia
  • Molecularly targeted therapy

ASJC Scopus subject areas

  • Medicine(all)

Cite this